ArticleWorld journal of urology2026
Using flow ratio of peritumoral artery/renal aorta from DSA imaging to predict high-risk clear cell renal cell carcinoma.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
purposeThe objective of this study was to evaluate the predictive value of the peritumoral artery-to-renal aorta flow ratio, derived from digital subtraction angiography, for identifying clear cell renal cell carcinoma at high risk of recurrence after nephrectomy.
methodsIn this prospective study, patients undergoing radical or partial nephrectomy for clear cell renal cell carcinoma between May 2025 and December 2025 were enrolled. Three experienced radiologists calculated the arterial flow ratio from preoperative DSA images using a novel, dedicated software solution. We employed univariate and multivariate logistic regression to determine the association between this hemodynamic parameter and postoperative pathological classification of high-risk clear cell renal cell carcinoma.
resultsAmong the 100 included patients, a flow ratio cutoff of 0.039 identified 34 patients (34%) with a high ratio. A high flow ratio of peritumoral artery/renal aorta was strongly associated with a pathological diagnosis of high-risk clear cell renal cell carcinoma (66.67% vs. 25.32%, P < 0.001). High-risk tumors exhibiting a high flow ratio were also significantly more likely to present at an advanced pathological T stage (≥ T2) (47.37% vs. 5.26%, P < 0.001). Crucially, a high flow ratio was confirmed as an independent predictor of high-risk clear cell renal cell carcinoma on multivariate analysis (Odds Ratio: 9.809; 95% Confidence Interval: 1.928–49.895; P = 0.006).
conclusionThe preoperative flow ratio of peritumoral artery/renal aorta, measured via DSA, is a significant and independent imaging biomarker associated with high-risk clear cell renal cell carcinoma. This novel parameter may aid in preoperative risk stratification.
Indexed as
Identifiers
41879872What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.